Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-29 @ 6:09 PM
Study NCT ID:
NCT00326456
Status:
UNKNOWN
Last Update Posted:
2023-03-27
First Post:
2006-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
Sponsor:
National Cancer Institute, Naples
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MITO-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None